BOSTON--(BUSINESS WIRE)--Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology ...
(RTTNews) - Matinas BioPharma Holdings, Inc. announced receipt of written feedback from FDA on its proposed revised protocol for a Phase 3 study of MAT2203 in patients with invasive aspergillosis with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback